-
1
-
-
0028216606
-
Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2
-
Y. Aboudy, E. Mendelson, I. Shalit, R. Bessalle, and M. Fridkin Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2 Int. J. Pept. Protein Res. 43 1994 573 582 (Pubitemid 24201381)
-
(1994)
International Journal of Peptide and Protein Research
, vol.43
, Issue.6
, pp. 573-582
-
-
Aboudy, Y.1
Mendelson, E.2
Shalit, I.3
Bessalle, R.4
Fridkin, M.5
-
2
-
-
44449126565
-
Inhibition of herpes simplex virus type 1 infection by cationic β-peptides
-
DOI 10.1128/AAC.01424-07
-
R. Akkarawongsa, T.B. Potocky, E.P. English, S.H. Gellman, and C.R. Brandt Inhibition of herpes simplex virus type 1 infection by cationic beta-peptides Antimicrob. Agents. Chemother. 52 2008 2120 2129 (Pubitemid 351758549)
-
(2008)
Antimicrobial Agents and Chemotherapy
, vol.52
, Issue.6
, pp. 2120-2129
-
-
Akkarawongsa, R.1
Potocky, T.B.2
English, E.P.3
Gellman, S.H.4
Brandt, C.R.5
-
3
-
-
1842637875
-
Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus
-
DOI 10.1016/j.ijantimicag.2003.07.022, PII S0924857903004151
-
V.C. Albiol Matanic, and V. Castilla Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus Int. J. Antimicrob. Agents 23 2004 382 389 (Pubitemid 38481551)
-
(2004)
International Journal of Antimicrobial Agents
, vol.23
, Issue.4
, pp. 382-389
-
-
Albiol Matanic, V.C.1
Castilla, V.2
-
4
-
-
4344615913
-
Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface
-
DOI 10.1002/jmv.20171
-
J.H. Andersen, H. Jenssen, K. Sandvik, and T.J. Gutteberg Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface J. Med. Virol. 74 2004 262 271 (Pubitemid 39150393)
-
(2004)
Journal of Medical Virology
, vol.74
, Issue.2
, pp. 262-271
-
-
Andersen, J.H.1
Jenssen, H.2
Sandvik, K.3
Gutteberg, T.J.4
-
5
-
-
0036137074
-
In vitro antiviral activity of dermaseptins against herpes simplex virus type 1
-
DOI 10.1002/jmv.2134
-
A. Belaid, M. Aouni, R. Khelifa, A. Trabelsi, M. Jemmali, and K. Hani In vitro antiviral activity of dermaseptins against herpes simplex virus type 1 J. Med. Virol. 66 2002 229 234 (Pubitemid 34020073)
-
(2002)
Journal of Medical Virology
, vol.66
, Issue.2
, pp. 229-234
-
-
Belaid, A.1
Aouni, M.2
Khelifa, R.3
Trabelsi, A.4
Jemmali, M.5
Hani, K.6
-
6
-
-
44449087318
-
Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virus
-
DOI 10.1073/pnas.0801388105
-
M.D. Bobardt, G. Cheng, L. de Witte, S. Selvarajah, U. Chatterji, B.E. Sanders-Beer, T.B. Geijtenbeek, F.V. Chisari, and P.A. Gallay Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virus Proc. Natl. Acad. Sci. U.S.A. 105 2008 5525 5530 (Pubitemid 351753896)
-
(2008)
Proceedings of the National Academy of Sciences of the United States of America
, vol.105
, Issue.14
, pp. 5525-5530
-
-
Bobardt, M.D.1
Cheng, G.2
De Witte, L.3
Selvarajah, S.4
Chatterji, U.5
Sanders-Beer, B.E.6
Geijtenbeek, T.B.H.7
Chisari, F.V.8
Gallay, P.A.9
-
7
-
-
84859856700
-
Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7
-
Y. Chen, L. Cao, M. Zhong, Y. Zhang, C. Han, Q. Li, J. Yang, D. Zhou, W. Shi, B. He, F. Liu, J. Yu, Y. Sun, Y. Cao, Y. Li, W. Li, D. Guo, Z. Cao, and H. Yan Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7 PLoS One 7 2012 e34947
-
(2012)
PLoS One
, vol.7
, pp. 34947
-
-
Chen, Y.1
Cao, L.2
Zhong, M.3
Zhang, Y.4
Han, C.5
Li, Q.6
Yang, J.7
Zhou, D.8
Shi, W.9
He, B.10
Liu, F.11
Yu, J.12
Sun, Y.13
Cao, Y.14
Li, Y.15
Li, W.16
Guo, D.17
Cao, Z.18
Yan, H.19
-
8
-
-
42949173539
-
A virocidal amphipathic α-helical peptide that inhibits hepatitis C virus infection in vitro
-
DOI 10.1073/pnas.0712380105
-
G. Cheng, A. Montero, P. Gastaminza, C. Whitten-Bauer, S.F. Wieland, M. Isogawa, B. Fredericksen, S. Selvarajah, P.A. Gallay, M.R. Ghadiri, and F.V. Chisari A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro Proc. Natl. Acad. Sci. U.S.A. 105 2008 3088 3093 (Pubitemid 351723672)
-
(2008)
Proceedings of the National Academy of Sciences of the United States of America
, vol.105
, Issue.8
, pp. 3088-3093
-
-
Cheng, G.1
Montero, A.2
Gastaminza, P.3
Whitten-Bauer, C.4
Wieland, S.F.5
Isogawa, M.6
Fredericksen, B.7
Selvarajah, S.8
Gallay, P.A.9
Ghadiri, M.R.10
Chisari, F.V.11
-
9
-
-
0036107516
-
Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease
-
DOI 10.1038/nm0402-386
-
J.J. Crute, C.A. Grygon, K.D. Hargrave, B. Simoneau, A.M. Faucher, G. Bolger, P. Kibler, M. Liuzzi, and M.G. Cordingley Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease Nat. Med. 8 2002 386 391 (Pubitemid 34407034)
-
(2002)
Nature Medicine
, vol.8
, Issue.4
, pp. 386-391
-
-
Crute, J.J.1
Grygon, C.A.2
Hargrave, K.D.3
Simoneau, B.4
Faucher, A.-M.5
Bolger, G.6
Kibler, P.7
Liuzzi, M.8
Cordingley, M.G.9
-
10
-
-
79955842117
-
HSV neutralization by the microbicidal candidate C5A
-
L. Lot de Witte, M.D. Bobardt, U. Chatterji, F.B. van Loenen, G.M. Verjans, T.B. Geijtenbeek, and P.A. Gallay HSV neutralization by the microbicidal candidate C5A PLoS One 6 2011 e18917
-
(2011)
PLoS One
, vol.6
, pp. 18917
-
-
Lot De Witte, L.1
Bobardt, M.D.2
Chatterji, U.3
Van Loenen, F.B.4
Verjans, G.M.5
Geijtenbeek, T.B.6
Gallay, P.A.7
-
11
-
-
0034980063
-
Herpes simplex virus antiviral drug resistance - Current trends and future prospects
-
DOI 10.1016/S1386-6532(00)00169-4, PII S1386653200001694
-
H.J. Field Herpes simplex virus antiviral drug resistance-current trends and future prospects J. Clin. Virol. 21 2001 261 269 (Pubitemid 32499236)
-
(2001)
Journal of Clinical Virology
, vol.21
, Issue.3
, pp. 261-269
-
-
Field, H.J.1
-
12
-
-
0023154559
-
Acyclovir prophylaxis for herpes simplex virus infection
-
D. Gold, and L. Corey Acyclovir prophylaxis for herpes simplex virus infection Antimicrob. Agents Chemother. 31 1987 361 367 (Pubitemid 17027121)
-
(1987)
Antimicrobial Agents and Chemotherapy
, vol.31
, Issue.3
, pp. 361-367
-
-
Gold, D.1
Corey, L.2
-
13
-
-
84863995606
-
Aptamer that binds to the gD protein of herpes simplex virus 1 and efficiently inhibits viral entry
-
S.C. Gopinath, K. Hayashi, and P.K. Kumar Aptamer that binds to the gD protein of herpes simplex virus 1 and efficiently inhibits viral entry J. Virol. 86 2012 6732 6744
-
(2012)
J. Virol.
, vol.86
, pp. 6732-6744
-
-
Gopinath, S.C.1
Hayashi, K.2
Kumar, P.K.3
-
14
-
-
33947637055
-
Novel targets for the development of anti-herpes compounds
-
A. Greco, J.J. Diaz, D. Thouvenot, and F. Morfin Novel targets for the development of anti-herpes compounds Infect. Disord.: Drug Targets 7 2007 11 18 (Pubitemid 46488256)
-
(2007)
Infectious Disorders - Drug Targets
, vol.7
, Issue.1
, pp. 11-18
-
-
Greco, A.1
Diaz, J.-J.2
Thouvenot, D.3
Morfin, F.4
-
15
-
-
0029930161
-
Quantitation of herpes simplex virus type 1 DNA and latency-associated transcripts in rabbit trigeminal ganglia demonstrates a stable reservoir of viral nucleic acids during latency
-
J.M. Hill, B.M. Gebhardt, R. Wen, A.M. Bouterie, H.W. Thompson, R.J. O'Callaghan, W.P. Halford, and H.E. Kaufman Quantitation of herpes simplex virus type 1 DNA and latency-associated transcripts in rabbit trigeminal ganglia demonstrates a stable reservoir of viral nucleic acids during latency J. Virol. 70 1996 3137 3141 (Pubitemid 26121931)
-
(1996)
Journal of Virology
, vol.70
, Issue.5
, pp. 3137-3141
-
-
Hill, J.M.1
Gebhardt, B.M.2
Wen, R.3
Bouterie, A.M.4
Thompson, H.W.5
O'Callaghan, R.J.6
Halford, W.P.7
Kaufman, H.E.8
-
16
-
-
84874259838
-
Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus
-
W. Hong, R. Zhang, Z. Di, Y. He, Z. Zhao, J. Hu, Y. Wu, W. Li, and Z. Cao Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus Biomaterials 34 2013 3511 3522
-
(2013)
Biomaterials
, vol.34
, pp. 3511-3522
-
-
Hong, W.1
Zhang, R.2
Di, Z.3
He, Y.4
Zhao, Z.5
Hu, J.6
Wu, Y.7
Li, W.8
Cao, Z.9
-
17
-
-
51349153234
-
Emodin is a novel alkaline nuclease inhibitor that suppresses herpes simplex virus type 1 yields in cell cultures
-
C.Y. Hsiang, and T.Y. Ho Emodin is a novel alkaline nuclease inhibitor that suppresses herpes simplex virus type 1 yields in cell cultures Br. J. Pharmacol. 155 2008 227 235
-
(2008)
Br. J. Pharmacol.
, vol.155
, pp. 227-235
-
-
Hsiang, C.Y.1
Ho, T.Y.2
-
18
-
-
0344304749
-
Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate
-
DOI 10.1016/j.antiviral.2003.09.001
-
H. Jenssen, J.H. Andersen, L. Uhlin-Hansen, T.J. Gutteberg, and O. Rekdal Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate Antiviral Res. 61 2004 101 109 (Pubitemid 37506097)
-
(2004)
Antiviral Research
, vol.61
, Issue.2
, pp. 101-109
-
-
Jenssen, H.1
Andersen, J.H.2
Uhlin-Hansen, L.3
Gutteberg, T.J.4
Rekdal, O.5
-
20
-
-
84876868755
-
Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody
-
A. Krawczyk, M.A. Arndt, L. Grosse-Hovest, W. Weichert, B. Giebel, U. Dittmer, H. Hengel, D. Jager, K.E. Schneweis, A.M. Eis-Hubinger, M. Roggendorf, and J. Krauss Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody Proc. Natl. Acad. Sci. U.S.A. 110 2013 6760 6765
-
(2013)
Proc. Natl. Acad. Sci. U.S.A.
, vol.110
, pp. 6760-6765
-
-
Krawczyk, A.1
Arndt, M.A.2
Grosse-Hovest, L.3
Weichert, W.4
Giebel, B.5
Dittmer, U.6
Hengel, H.7
Jager, D.8
Schneweis, K.E.9
Eis-Hubinger, A.M.10
Roggendorf, M.11
Krauss, J.12
-
21
-
-
79960340064
-
Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses
-
Q. Li, Z. Zhao, D. Zhou, Y. Chen, W. Hong, L. Cao, J. Yang, Y. Zhang, W. Shi, Z. Cao, Y. Wu, H. Yan, and W. Li Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses Peptides 32 2011 1518 1525
-
(2011)
Peptides
, vol.32
, pp. 1518-1525
-
-
Li, Q.1
Zhao, Z.2
Zhou, D.3
Chen, Y.4
Hong, W.5
Cao, L.6
Yang, J.7
Zhang, Y.8
Shi, W.9
Cao, Z.10
Wu, Y.11
Yan, H.12
Li, W.13
-
22
-
-
77951294418
-
A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry
-
R. Liu, M. Tewari, R. Kong, R. Zhang, P. Ingravallo, and R. Ralston A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry Antiviral Res. 86 2010 172 179
-
(2010)
Antiviral Res.
, vol.86
, pp. 172-179
-
-
Liu, R.1
Tewari, M.2
Kong, R.3
Zhang, R.4
Ingravallo, P.5
Ralston, R.6
-
23
-
-
77954752067
-
Molecular diversity of toxic components from the scorpion Heterometrus petersii venom revealed by proteomic and transcriptome analysis
-
Y. Ma, Y. Zhao, R. Zhao, W. Zhang, Y. He, Y. Wu, Z. Cao, L. Guo, and W. Li Molecular diversity of toxic components from the scorpion Heterometrus petersii venom revealed by proteomic and transcriptome analysis Proteomics 10 2010 2471 2485
-
(2010)
Proteomics
, vol.10
, pp. 2471-2485
-
-
Ma, Y.1
Zhao, Y.2
Zhao, R.3
Zhang, W.4
He, Y.5
Wu, Y.6
Cao, Z.7
Guo, L.8
Li, W.9
-
24
-
-
78650060808
-
Manzamine A as a novel inhibitor of herpes simplex virus type-1 replication in cultured corneal cells
-
J.R. Palem, G.R. Bedadala, K.A. El Sayed, and S.C. Hsia Manzamine A as a novel inhibitor of herpes simplex virus type-1 replication in cultured corneal cells Planta Med. 77 2011 46 51
-
(2011)
Planta Med.
, vol.77
, pp. 46-51
-
-
Palem, J.R.1
Bedadala, G.R.2
El Sayed, K.A.3
Hsia, S.C.4
-
25
-
-
0037308626
-
NP-1, a rabbit α-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2
-
DOI 10.1128/AAC.47.2.494-500.2003
-
S. Sinha, N. Cheshenko, R.I. Lehrer, and B.C. Herold NP-1, a rabbit alpha-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2 Antimicrob. Agents Chemother. 47 2003 494 500 (Pubitemid 36158072)
-
(2003)
Antimicrobial Agents and Chemotherapy
, vol.47
, Issue.2
, pp. 494-500
-
-
Sinha, S.1
Cheshenko, N.2
Lehrer, R.I.3
Herold, B.C.4
-
26
-
-
34247107234
-
Sialic acid on herpes simplex virus type 1 envelope glycoproteins is required for efficient infection of cells
-
DOI 10.1128/JVI.02250-06
-
J.R. Teuton, and C.R. Brandt Sialic acid on herpes simplex virus type 1 envelope glycoproteins is required for efficient infection of cells J. Virol. 81 2007 3731 3739 (Pubitemid 46586870)
-
(2007)
Journal of Virology
, vol.81
, Issue.8
, pp. 3731-3739
-
-
Teuton, J.R.1
Brandt, C.R.2
-
27
-
-
78650521049
-
A new natural alpha-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV
-
R. Yan, Z. Zhao, Y. He, L. Wu, D. Cai, W. Hong, Y. Wu, Z. Cao, C. Zheng, and W. Li A new natural alpha-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV Peptides 32 2011 11 19
-
(2011)
Peptides
, vol.32
, pp. 11-19
-
-
Yan, R.1
Zhao, Z.2
He, Y.3
Wu, L.4
Cai, D.5
Hong, W.6
Wu, Y.7
Cao, Z.8
Zheng, C.9
Li, W.10
-
28
-
-
0034116709
-
Evaluation of the inactivation of infectious herpes simplex virus by host-defense peptides
-
B. Yasin, M. Pang, J.S. Turner, Y. Cho, N.N. Dinh, A.J. Waring, R.I. Lehrer, and E.A. Wagar Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides Eur. J. Clin. Microbiol. Infect. Dis. 19 2000 187 194 (Pubitemid 30201294)
-
(2000)
European Journal of Clinical Microbiology and Infectious Diseases
, vol.19
, Issue.3
, pp. 187-194
-
-
Yasin, B.1
Pang, M.2
Turner, J.S.3
Cho, Y.4
Dinh, N.-N.5
Waring, A.J.6
Lehrer, R.I.7
Wagar, E.A.8
-
29
-
-
2342573669
-
θ Defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry
-
DOI 10.1128/JVI.78.10.5147-5156.2004
-
B. Yasin, W. Wang, M. Pang, N. Cheshenko, T. Hong, A.J. Waring, B.C. Herold, E.A. Wagar, and R.I. Lehrer Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry J. Virol. 78 2004 5147 5156 (Pubitemid 38581467)
-
(2004)
Journal of Virology
, vol.78
, Issue.10
, pp. 5147-5156
-
-
Yasin, B.1
Wang, W.2
Pang, M.3
Cheshenko, N.4
Hong, T.5
Waring, A.J.6
Herold, B.C.7
Wagar, E.A.8
Lehrer, R.I.9
-
30
-
-
84862833294
-
Virucidal mechanism of action of NVC-422, a novel antimicrobial drug for the treatment of adenoviral conjunctivitis
-
J. Yoon, A. Jekle, R. Najafi, F. Ruado, M. Zuck, B. Khosrovi, B. Memarzadeh, D. Debabov, L. Wang, and M. Anderson Virucidal mechanism of action of NVC-422, a novel antimicrobial drug for the treatment of adenoviral conjunctivitis Antiviral Res. 92 2011 470 478
-
(2011)
Antiviral Res.
, vol.92
, pp. 470-478
-
-
Yoon, J.1
Jekle, A.2
Najafi, R.3
Ruado, F.4
Zuck, M.5
Khosrovi, B.6
Memarzadeh, B.7
Debabov, D.8
Wang, L.9
Anderson, M.10
-
31
-
-
84865795778
-
Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4alpha in vitro and in vivo
-
Z. Zhao, W. Hong, Z. Zeng, Y. Wu, K. Hu, X. Tian, W. Li, and Z. Cao Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4alpha in vitro and in vivo J. Biol. Chem. 287 2012 30181 30190
-
(2012)
J. Biol. Chem.
, vol.287
, pp. 30181-30190
-
-
Zhao, Z.1
Hong, W.2
Zeng, Z.3
Wu, Y.4
Hu, K.5
Tian, X.6
Li, W.7
Cao, Z.8
|